Personalis, Inc.
NASDAQ:PSNLMedical - Diagnostics & Research
+$0.34 today
- Market cap
- $1.62B
- Beta
- 2.28
- P/E (TTM)
- -11.0
- EPS (TTM)
- -$0.92
Volume 1.47M
Average 2.31M
PSNL Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Personalis, Inc.NASDAQ: PSNL
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin growth accelerates
Q1 FY2026 selling, general & admin of $17.9M rose 46.0% year over year, ahead of the +26.4% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 27.0% from the prior quarter. Over 3 fiscal years it compounded at -5.7% a year.
Context
- Selling, general & admin increased in 1 of the last 3 fiscal years.
What to watch
Whether selling, general & admin reaches the consensus estimate from 1 analysts of $60.4M (+12.7%) for the fiscal year ending Dec 2026, a slowdown from the +16.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $17.9M+27.0% QoQ
- Last fiscal yearDec 2025
- $53.57M+16.0% YoY
- LTMMar 2026
- $59.21M+26.4% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 53.57M USD
- Year-over-year change
- +16.0%
- 4-year CAGR
- +2.9%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 53.57M | +16.0% |
| FY2024 | 2024-12-31 | 46.19M | -7.1% |
| FY2023 | 2023-12-31 | 49.73M | -22.3% |
| FY2022 | 2022-12-31 | 63.97M | +34.1% |
| FY2021 | 2021-12-31 | 47.7M | — |
Selling, General & Admin vs competitors
How PSNL compares with its peers on the latest reported figures
- PSNL's LTM Mar 2026 selling, general & admin of $59.21M is the lowest of the 10 companies compared; the peer median is $292.26M.
- Its year-over-year change of +26.4% is the 5th highest of 10, against a peer median of +22.3%.
- Selling, general & admin amounts to 91.8% of revenue for PSNL, versus a peer median of 51.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.25B | +22.3% | +26.0% | 46.4% | |
| LTM Sep 2026 | $951.07M | +44.5% | +15.0% | 74.4% | |
| LTM Mar 2026 | $537.7M | -3.2% | +1.5% | 64.9% | |
| LTM Jun 2026 | $359.09M | +0.6% | +9.5% | 46.9% | |
WGSGeneDx Holdings Corp. | LTM Jun 2026 | $292.26M | +58.0% | -10.9% | 64.3% |
| LTM Jun 2026 | $291.09M | -3.7% | -2.4% | 176.1% | |
| LTM Jun 2026 | $201.58M | -7.5% | +6.6% | 35.9% | |
BLLNBillionToOne, Inc. | LTM Jun 2026 | $180.71M | +60.0% | — | 45.5% |
| LTM Mar 2026 | $166.18M | +30.2% | +2.2% | 51.9% | |
| LTM Mar 2026 | $59.21M | +26.4% | -5.7% | 91.8% | |
| Peer median (excluding PSNL) | $292.26M | +22.3% | +4.4% | 51.9% | |
Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 85.49M | 65.05M | 73.48M | 84.61M | 0 |
| Cost of Revenue | 53.84M | 51.7M | 55.27M | 57.79M | 53.87M |
| Gross Profit | 31.66M | 13.35M | 18.21M | 26.83M | (53.87M) |
| Gross Margin | 37.0% | 20.5% | 24.8% | 31.7% | — |
| Research & Development | 49.31M | 64.91M | 64.78M | 48.91M | 50.26M |
| Selling, General & Admin | 47.7M | 63.97M | 49.73M | 46.19M | 53.57M |
| Operating Expenses | 97.01M | 128.88M | 128.14M | 95.09M | 34.19M |
| Depreciation & Amortization | 6.01M | 8.43M | 11.3M | 10.94M | 10.05M |
| EBITDA | (59.01M) | (104.64M) | (96.81M) | (70.3M) | (71M) |
| EBITDA Margin | -69.0% | -160.9% | -131.7% | -83.1% | — |
| Operating Income | (65.35M) | (115.53M) | (109.94M) | (68.27M) | (88.06M) |
| Operating Margin | -76.4% | -177.6% | -149.6% | -80.7% | — |
| Interest Income | 367K | 2.4M | 5.9M | 5.51M | 7.16M |
| Interest Expense | 184K | 201K | 110K | 24K | 205K |
| Other Income / Expenses | 141K | 2.26M | 1.72M | (13M) | 6.81M |
| Income Before Tax | (65.21M) | (113.28M) | (108.21M) | (81.27M) | (81.25M) |
| Pre-Tax Margin | -76.3% | -174.1% | -147.3% | -96.0% | — |
| Income Tax Expense | 14K | 40K | 83K | 18K | 21K |
| Net Income | (65.23M) | (113.32M) | (108.3M) | (81.28M) | (81.27M) |
| Net Margin | -76.3% | -174.2% | -147.4% | -96.1% | — |
| EPS (Basic) | (1.49) | (2.48) | (2.25) | (1.37) | (0.91) |
| EPS (Diluted) | (1.49) | (2.48) | (2.25) | (1.37) | (0.91) |
| Weighted Avg Shares | 43.89M | 45.7M | 48.18M | 59.25M | 89.24M |
| Weighted Avg Shares (Diluted) | 43.89M | 45.7M | 48.18M | 59.25M | 89.24M |
Personalis, Inc.
NASDAQ:PSNL
Intrinsic Alpha fair value
Locked
Current Price
$14.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.